The El Salvador 2024 Sessions are coming soon

The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador). The event will present a scientific program of high academic level and a large number of national and international guests to discuss the most relevant topics of current Latin American interventional cardiology.

November 7 & 8, 2024.

These Sessions are organized by SOLACI, and is aimed at interventional cardiologists, clinical cardiologists, hemodynamic technicians and nurses, and anyone who would like to update and grow professionally.

More information below:

 

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Más artículos de este Autor

ACC 2026: SURViV Trial Results – Exclusive Presentation and Analysis with Dr. Dimytri Siqueira

Following the presentation of the SURViV trial in the Late Breaking Clinical Trials sessions at the American College of Cardiology Congress, Dr. Dimytri Siqueira...

SOLACI Technicians Webinar – Ultrasound Pulses + Calcium = Coronary Lithotripsy

The Latin American Society of Interventional Cardiology (SOLACI) invites you to participate in a new Live SOLACI Webinar specially designed for technicians, nurses, and...

COMPLICAT 2026: Collaborative learning to address complications in congenital and structural heart disease

Free online course in Spanish5 webinars in 2026 COMPLICAT 2026 returns with its second edition, consolidating itself as an innovative academic space dedicated to the...

CHIP LATAM | Chapter 2 – Mexico: Complications Workshop

The Latin American Society of Interventional Cardiology invites the entire medical community to participate in a virtual workshop on complications organized by SOLACI’s Complex...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Artículos relacionados

Jornadas SOLACIspot_img

Artículos recientes

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...